Cutler Group’s Protalix BioTherapeutics PLX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-10,067	Closed	-$8K	–	2411
2021 Q4	$8K	Sell	10,067 -1,200	-11%	-$954	﹤0.01%	1721
2021 Q3	$14K	Buy	11,267 +4,367	+63%	+$5.43K	﹤0.01%	1626
2021 Q2	$13K	Buy	+6,900	New	+$13K	﹤0.01%	1650